Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2019-11-08 Regulatory Filings
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions that the company issued a press release announcing financial results for the quarter ended September 30, 2019, and that the press release is attached as an exhibit. The document itself does not contain the full financial statements or detailed financial analysis but rather references the press release. The length of the document is 4109 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces or attaches a report but does not contain the full report itself should be classified as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2019-11-08 English
FORM 10-Q
Interim / Quarterly Report Q3 2019
2019-11-07 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-30 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-30 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-30 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.